Richard Easom

Richard Easom is an accomplished professional in the fields of biochemistry, molecular biology, and medical liaison, with extensive experience in diabetes and cardiovascular diseases. Currently serving as an Executive Medical Liaison at Novo Nordisk since April 2012, Richard has previously held various positions, including Senior Clinical Science Liaison at Takeda Pharmaceuticals and Associate Professor at the University of North Texas Health Science Center. Richard's academic credentials include a PhD in Biochemistry, Physiology, and Dairy Science from Washington University in St. Louis, complemented by a B.Sc (hons) in Biochemistry from the University of Bath. Notable contributions to diabetes research and education have been made through leadership roles in academia as well as collaborations with healthcare professionals and thought leaders throughout the Midwest.